Marinus Pharmaceuticals reported $73.29M in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
ALKERMES ALKS:US USD -63974000 33.84M
Amgen AMGN:US USD 1.62B 527M
Aptinyx Inc APTX:US USD -15303000 2.36M
Biogen BIIB:US USD 1.13B 76.7M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Gilead Sciences GILD:US USD 1.64B 149M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Intra Cellular Therapies ITCI:US USD -53508000 33.1M
Marinus Pharmaceuticals MRNS:US USD 73.29M 112.72M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Ptc Therapeutics PTCT:US USD -109315000 42.77M
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M